双侧甲状腺病变影像1则

2018-09-07 佚名 影像园

女,52岁,突发颈部肿物伴呼吸困难半日

【所属科室】

内分泌科

【基本资料】

女,52岁

【主诉】

突发颈部肿物伴呼吸困难半日

【现病史】

患者发现甲状腺双叶多发肿物1年余,肿物逐渐增大,未予重视。昨晚无明显诱因肿物突然增大,位于颈部右侧,约5x5cm,质韧,光滑,与周围组织分界清,随吞咽上下活动。伴有压痛,伴轻度呼吸困难,无吞咽困难。

【影像图片】






【讨论】

评论:双侧甲状腺形态不对称,气管尚居中,右侧甲状腺体积增大,呈欠规则结节状稍高密度影,边界尚清。左侧甲状腺见小结节状稍低密度影,边界模糊。增强扫描右侧甲状腺病变未见强化,左侧甲状腺病变轻度强化。考虑:1)甲状腺肿;2)腺瘤
 
【结果】

(右侧甲状腺及肿物)结节性甲状腺肿伴出血、囊性变。
(左甲状腺)结节性甲状腺肿。

【病例小结】

甲状腺肿主要是由于缺碘引起的甲状腺代偿性增生,不伴由明显的甲状腺功能异常。初期甲状腺增大为弥漫性,可逐渐发展为结节状。

弥漫性甲状腺肿的病因可能是饮食中缺碘或甲状腺功能亢进或炎症。地方性甲状腺肿主要流行于碘缺乏区,女性居多,发病高峰为青春期。随时间推移,单纯性甲状腺肿可以发展为多结节性甲状腺肿,表现为甲状腺非对称性增大,可伸向胸骨后或上纵隔。75%~80%的胸骨后甲状腺肿起源于甲状腺下极或峡部。甲状腺内可见多发结节,并有局灶性出血、钙化、囊性变和瘢痕形成。

CT:单纯性甲状腺肿表现为甲状腺弥漫性肿大。甲状腺组织的CT值多在70HU以上。多结节性甲状腺肿则表现为甲状腺非对称性增大,伴有退行性变,出血、囊变、坏死或片状钙化则致密度不均。增强扫描,甲状腺组织增强,囊变坏死区不强化。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=345177, encodeId=51713451e7e8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/18/9fba4e8a3782366829a5645367fdb658.jpg, createdBy=b5732293938, createdName=青山颖钰, createdTime=Sun Sep 16 05:51:57 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522413, encodeId=5dfb152241397, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sun Sep 09 09:25:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343695, encodeId=20ce343695ff, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 08 08:52:27 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343455, encodeId=f9073434555a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Sep 07 20:12:24 CST 2018, time=2018-09-07, status=1, ipAttribution=)]
    2018-09-16 青山颖钰

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=345177, encodeId=51713451e7e8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/18/9fba4e8a3782366829a5645367fdb658.jpg, createdBy=b5732293938, createdName=青山颖钰, createdTime=Sun Sep 16 05:51:57 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522413, encodeId=5dfb152241397, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sun Sep 09 09:25:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343695, encodeId=20ce343695ff, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 08 08:52:27 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343455, encodeId=f9073434555a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Sep 07 20:12:24 CST 2018, time=2018-09-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=345177, encodeId=51713451e7e8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/18/9fba4e8a3782366829a5645367fdb658.jpg, createdBy=b5732293938, createdName=青山颖钰, createdTime=Sun Sep 16 05:51:57 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522413, encodeId=5dfb152241397, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sun Sep 09 09:25:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343695, encodeId=20ce343695ff, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 08 08:52:27 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343455, encodeId=f9073434555a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Sep 07 20:12:24 CST 2018, time=2018-09-07, status=1, ipAttribution=)]
    2018-09-08 liumin1987

    嗯嗯,学习了。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=345177, encodeId=51713451e7e8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/18/9fba4e8a3782366829a5645367fdb658.jpg, createdBy=b5732293938, createdName=青山颖钰, createdTime=Sun Sep 16 05:51:57 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522413, encodeId=5dfb152241397, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Sun Sep 09 09:25:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343695, encodeId=20ce343695ff, content=嗯嗯,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Sat Sep 08 08:52:27 CST 2018, time=2018-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=343455, encodeId=f9073434555a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Sep 07 20:12:24 CST 2018, time=2018-09-07, status=1, ipAttribution=)]
    2018-09-07 医者仁心5538

    学习了

    0

相关资讯

急性双侧基底节病变综合征1例

患者女,49岁。因“10d前出现构音障碍、四肢不自主颤动”收治入院。

Neurology:双侧对称性弧形视野缺损

48岁,男性。心肺复苏后出现管状视野。

J Spinal Disord Tech:经皮椎体成形术单侧疗效优于双侧

骨质疏松性椎体压缩性骨折(OVCFs)是导致腰痛和行动能力丧失的一个常见问题。置入许多固定器具的传统开放式手术因疏松的骨质固定性不好而经常失败。 经皮椎体成形术(VP)是一种安全有效的治疗手段。经典的VP通过双侧经椎弓根或椎弓根外将骨水泥注入。许多学者将VP的技术挑战视为重度椎体压缩性骨折的相对或绝对禁忌症。然而,最近有研究报道称单侧VP可以达到同样的疗效。理论上来讲,单侧VP可以减少手

急性双侧半球脑出血手术3例

女,31岁。因“头痛、恶心17h,被人发现意识不清2h”于2015年10月8日入院。

JBJS:双膝同期置换在院并发症发生率高

人工全膝关节置换术(TKA)是是一种疗效确切、成本效益良好的常见外科手术。随着人口老龄化和手术指征的扩大,预计未来二十年TKA的手术需求将会有明显增长。这些患者往往同时双侧膝关节受累,因此医生和患者需要决定应该采用同期双侧TKA还是分次手术。 同期双侧TKA的潜在优势主要在于缩短了住院日、更短的麻醉时间、更短的康复时间及更少的医疗费用,除此以外,同期双侧TKA在功能结果、放射学结果、疼痛

BMJ:卵细胞浆内单精子注射后双侧输卵管异位妊娠

双侧输卵管异位妊娠是一种特殊的临床状态,其发病率约为自然妊娠的1/200000 。而体外受精异位妊娠的发病率约占所有临床妊娠的2.1%-9.4%。据报道,仅有一小部分双侧异位妊娠的患者在接受药物治疗后能正常宫内妊娠,并且成功分娩。 目前,有关卵细胞浆内单精子注射和胚胎移植(ICSI-ET)后双侧输卵管异位妊娠的病例报道很少,输卵管异位妊娠发病率的相关数据还不完善。Mehtap Polat